You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

Article info

Article menu

Download PDFPDF

XML
Research Article
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

Authors

  • Derek L. Clouthier Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Scott C. Lien Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • S. Y. Cindy Yang Department of Medical BiophysicsUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Linh T. Nguyen Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Venkata S. K. Manem Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of Medical BiophysicsUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Diana Gray Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Michael Ryczko Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Albiruni R. A. Razak Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Jeremy Lewin Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Stephanie Lheureux Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Ilaria Colombo Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Philippe L. Bedard Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • David Cescon Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Anna Spreafico Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Marcus O. Butler Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Aaron R. Hansen Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Raymond W. Jang Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Sangeet Ghai Princess Margaret Cancer Centre, University Health Network Toronto Canada Joint Department of Medical ImagingUniversity Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Ilan Weinreb Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Valentin Sotov Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Ramy Gadalla Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Babak Noamani Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Mengdi Guo Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Sawako Elston Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Amanda Giesler Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Sevan Hakgor Princess Margaret Cancer Centre, University Health Network Toronto Canada PubMed articlesGoogle scholar articles
  • Haiyan Jiang Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of BiostatisticsPrincess Margaret Cancer Centre Toronto Canada PubMed articlesGoogle scholar articles
  • Tracy McGaha Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • David G. Brooks Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Benjamin Haibe-Kains Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of Medical BiophysicsUniversity of Toronto Toronto Canada Department of Computer ScienceUniversity of Toronto Toronto Canada Ontario Institute of Cancer Research Toronto Canada Vector Institute Toronto ON Canada PubMed articlesGoogle scholar articles
  • Trevor J. Pugh Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of Medical BiophysicsUniversity of Toronto Toronto Canada Ontario Institute of Cancer Research Toronto Canada PubMed articlesGoogle scholar articles
  • Pamela S. Ohashi Princess Margaret Cancer Centre, University Health Network Toronto Canada Department of ImmunologyUniversity of Toronto Toronto Canada Department of Medical BiophysicsUniversity of Toronto Toronto Canada PubMed articlesGoogle scholar articles
  • Lillian L. Siu Princess Margaret Cancer Centre, University Health Network Toronto Canada Division of Medical Oncology and Hematology, Department of MedicineUniversity of Toronto Toronto Canada Division of Medical Oncology and HematologyPrincess Margaret Cancer Centre 700 University Ave M5G 1Z5 Toronto ON Canada PubMed articlesGoogle scholar articles

Citation

Clouthier DL, Lien SC, Yang SYC, et al
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Journal for ImmunoTherapy of Cancer 2019;7:72. doi: 10.1186/s40425-019-0541-0
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.